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Abstract 
Depression co-occurs in 20 % of people with cardiovascular disorders, can persist for years, and 
predicts worse physical health outcomes. While psychosocial treatments have been shown to treat acute 
depression effectively in those with comorbid cardiovascular disorders, to date, there has been no evaluation of 
approaches aiming to prevent relapse and treat residual depression symptoms in this group. Consequently, the 
current study aimed to examine the feasibility and acceptability of a randomised controlled trial design 
evaluating an adapted version of mindfulness-based cognitive therapy (MBCT) designed specifically for people 
with co-morbid depression and cardiovascular disorders. A 3-arm feasibility randomised controlled trial was 
conducted, comparing MBCT adapted for people with cardiovascular disorders plus treatment as usual (TAU), 
mindfulness-based stress reduction (MBSR) plus TAU, and TAU alone. Participants completed a set of self-
report measures of depression severity, anxiety, quality of life, illness perceptions, mindfulness, self-compassion 
and affect and had their blood pressure taken immediately before, after, and three months following the 
intervention. Those in the adapted-MBCT arm additionally underwent a qualitative interview to gather their 
views about the adapted intervention. 3,400 potentially eligible participants were approached when attending an 
outpatient appointment at a cardiology clinic or via a GP letter following a case note search. 242 (7.1 %) were 
interested in taking part, 59 (1.7 %) were screened as being suitable, and 33 (<1 %) were eventually randomised 
to the three groups. Of 11 participants randomised to adapted MBCT, seven completed the full course, levels of 
home mindfulness practice were high, and positive qualitative feedback about the intervention was given. 
Twenty-nine out of 33 randomised participants completed all the assessment measures at all three-time points. 
The means PHQ-9 scores for the MBCT-HeLM group were lower at post-intervention and at the three-month 
follow-up compared to the MBSR and TAU groups. The sample was heterogeneous in terms of whether they 
reported current depression or had a history of depression and the time since the onset of cardiovascular 
disorders (one to 25 years). The adapted MBCT intervention was feasible and acceptable to participants, 
however, certain aspects of the trial design were not. In particular, low recruitment rates were achieved and 
there was a high withdrawal rate between screening and randomisation. Moreover, the heterogeneity in the 
sample was high, meaning the adapted intervention was unlikely to be well tailored to all the participants needs. 
This suggests that if the decision is made to move to a definitive trial, study recruitment procedures will need to 
be revised to recruit a target sample that optimally matches the adapted intervention.   
Keywords: MBCT, depression, cardiovascular disorders, feasibility, acceptability. 
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Background 
Depression occurs in approximately 20 % of people with cardiovascular disorders (CVDs) (Davidson, 
2012; Huffman, Celano, Beach, Motiwala, & Januzzi, 2013), often running a chronic and/or recurrent course; 
being associated with significant functional impairment in its own right and predicting worse medical outcomes 
(Baumeister, Haschke, Munzinger, Hutter, & Tully, 2015; Pelletier et al., 2015). The comorbidity between 
depression and CVDs is associated with poor medication adherence and reduced physical and psychological 
quality of life (Dickens, Cherrington, & McGowan, 2012; Rustad, Stern, Hebert, & Musselman, 2013). 
Moreover, this comorbidity predicts a substantial increase in hospital admission rates and the use of health 
services (Baumeister et al., 2015; Guthrie et al., 2016). Notably, depression is often associated with an increase 
in essential CVD risk factors, including unhealthy behaviours, such as poor diet and smoking (Katon, 2011; 
Luppino et al., 2010). This comorbidity also negatively affects people self-care (Cameron, Worrall-Carter, 
Riegel, Lo, & Stewart, 2009; Riegel, Lee, & Dickson, 2011) and leads to a greater inability to perform routine 
activities (Walters, Barley Mann & Phillips, 2014). 
There may be underlying psycho-biological mechanisms in depression that directly exacerbate 
cardiovascular risk (Carlson, 2012; Naylor et al., 2012). In terms of biological factors, both depression and 
CVDs are associated with elevated platelet activation and inflammation (Dickens, 2015; Guarneri, Mercado & 
Suhar, 2009). On the psychological level, people with these conditions experience low self-efficacy, low self-
care and negative illness perceptions (Greco et al., 2014; Morgan, Villiers-Tuthill, Barker, & Mcgee, 2014; 
Sarkar, Ali, & Whooley, 2007; Volz, Mobus, Letsch, & Werheid, 2016). In addition, perseverative negative 
cognitive processes (worry about the future and rumination about the past) have been associated with symptoms 
of depression (Nolen-Hoeksema, 1991). Rumination has been shown to increase the likelihood, severity and 
duration of depression (Watkins, 2008; Watkins & Teasdale, 2004). Also, these perseverative cognitive 
processes were found to be associated with CVDs, such as coronary heart disease and hypertension (Gerin et al., 
2012; Kubzansky et al., 1997; Radstaak, Geurts, Brosschot, Cillessen, & Kompier, 2011). Consequently, 
effective psychosocial treatments need to be developed to manage depression in this group, both to counter it 
and to enhance physical health outcomes.  
Mindfulness-based programmes already have a proven track record in addressing both physical and 
mental health symptoms. Mindfulness is defined as “paying attention in a particular way: on purpose, in the 
present moment, and non-judgementally” (Kabat-Zinn, 1994, p. 4). Mindfulness-based programmes are based 
on some common, essential features, including a shared model of human experience, which addresses the causes 
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of human distress and pathways to relieving it, and the centrality of mindfulness practice as an experiential 
inquiry-based learning process. However, different programmes have somewhat different emphases, depending 
on their specific intentions, the target contexts and populations (Crane et al., 2017). Mindfulness-Based Stress 
Reduction (MBSR) and Mindfulness-Based Cognitive Therapy (MBCT) were developed as approaches to 
develop “a new relationship” with experience characterised by present moment focus, decentring and an 
approach orientation” (Crane et al., 2017). They constitute a range of formal mindfulness practices as a key 
method for training attentional control as well as the non-judgemental attitudinal dimensions of mindfulness 
(Crane et al., 2017).  
MBSR was first developed to help people with chronic health problems better manage pain, health and 
their lives (Kabat-Zinn, 1990, 2013). The intention is for participants to learn to bring non-judgmental 
awareness to present-moment experience and learn skilful ways of responding to physical and emotional pain. 
During MBSR, participants learn a set of mindfulness practices that include focus on the breath and body as 
well as yoga. MBSR has been found to have positive effects on anxiety, depression and worry (Hoge et al., 
2013) as well as some physical symptoms, such as high blood pressure (Carlson, Speca, Faris, & Patel, 2007; 
Hughes et al., 2013). However, other studies have found that it does not have effects on physical symptoms, 
including high blood pressure (Blom et al., 2014; Campbell, Labelle, Bacon, Faris, & Carlson, 2012). 
MBCT combines mindfulness practices and certain cognitive therapy techniques to target negative 
thinking styles in individuals with a history of depression, who are at high risk of depressive relapse and 
recurrence (Segal, Williams & Teasdale, 2002, 2013). It is based on psychological models of mechanisms that 
maintain and exacerbate common psychological problems and uses behavioural, cognitive and mindfulness 
strategies (Michalak, Holz, & Teismann, 2011; van Aalderen et al., 2012). It helps people recognise and 
decentre from habitual patterns of thinking and behaving (Kuyken et al., 2010), thereby facilitating more 
resilient responses to challenges. MBCT addresses both universal vulnerabilities addressed by any mindfulness-
based intervention and specific ones implicated in depressive relapse (Crane et al., 2017). Whilst MBCT was 
originally designed as an approach to preventing depressive relapse in people at risk of depression (Kearns et al., 
2015; Kuyken et al., 2016), it  has also been evaluated in people with sub-clinical residual symptoms 
(Eisendrath et al., 2016) and people suffering from physical health conditions (Schoultz, Atherton, & Watson, 
2015; van Son et al., 2014). MBCT has demonstrated positive effects on worry, rumination, positive and 
negative affect, mindfulness and self-compassion (Geschwind, Peeters, Drukker, van Os, & Wichers, 2011; 
Kearns et al., 2015; Kuyken et al., 2008; van Aalderen et al., 2012).  To the best of our knowledge, there has 
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only been one study that has examined the effects of MBCT on depression in people with coronary heart disease 
(CHD) (O’Doherty et al., 2015). Whilst the outcomes of this study indicated that people in the MBCT group 
showed improvements regarding current depression, anxiety, quality of life and illness perceptions compared to 
a waiting list group, the non-randomised design used precludes strong conclusions from being drawn. Moreover, 
limited information is provided about the adaptations made to the MBCT programme for CHD and hence,, 
further research is needed. 
Maximising the potential benefits of MBCT for people with comorbid depression and CVD requires 
careful consideration of the mechanisms that drive psychological distress in people with CVD as well as their 
particular intentions and functional limitations. In particular, standard MBCT focuses mainly on depression 
specific mechanisms; for example, rumination about causes, meanings and the consequences of low mood. 
However, people with cardiovascular disorders worry about the cardiovascular event returning or the causes, 
meanings and consequences of a cardiac condition (Larsen & Christenfeld, 2009; Rozanski, Blumenthal, & 
Kaplan, 1999). Moreover, given the nature of cardiovascular disorders, the body cannot be assumed to provide a 
safe, neutral anchor for mindfulness practice and a different focus may be required; attending to bodily 
sensations may increase anxiety by activating worries of a further cardiac event, which can increase pulse and/or 
heart rate. Furthermore, a number of studies have indicated that people with CVDs have low confidence 
regarding their ability to take care of their condition, also known as self-efficacy, and the associated impacts on 
their self-care, which can lead to worse medical outcomes (Greco et al., 2014; Riegel et al., 2011; Tovar et al., 
2015; Volz et al., 2016). Hence, care is needed to consider how best to enhance self-efficacy.  
MBCT adaptations are intended to target more specifically the mechanisms that drive both depression 
and cardiovascular disorders (e.g., rumination and worry specific to CVD, lower self-efficacy and poor self-
care) as well as the general mechanisms targeted by any mindfulness-based intervention (Alsubaie et al., 2017).  
Therefore, we are interested in examining whether adapted-MBCT adds value over and above MBSR, because it 
(a) includes a more specific hypothesised mechanism that drives the distress associated with CVDs and mood 
problems and (b) uses cognitive and behavioural strategies alongside those employed in MBSR. To examine this 
uncertainty requires a 3-arm design comparing adapted-MBCT + TAU, vs MBSR + TAU vs TAU alone. We 
hypothesised that MBCT adapted for people with depression and cardiovascular disorders would be more 
acceptable and effective than MBSR and TAU. To help ensure the adaptations made to MBCT were optimally 
effective and likely to be implementable in practice, for our project, the Heart and Living Mindfully “HeLM”, 
we followed the recent UK Medical Research Council guidelines (MRC) for developing complex interventions 
6 
 
(Craig et al., 2008) and the National Institutes of Health (NIH) stage model (Onken, Carroll, Shoham, Cuthbert, 
& Riddle, 2014). First, we established the evidence base around adapting MBCT for physical health conditions 
by conducting two systematic reviews (Abbott et al., 2014; Alsubaie et al., 2017). Second, an MBCT manual 
was adapted for people with depression and cardiovascular disorders, following a co-design process with 
service-users and clinicians. Third, this manual was iteratively piloted with two groups of participants. The 
current study represents the final phase of the project, namely, a feasibility RCT to establish MBCT-HeLM’s 
feasibility and preliminary acceptability. Feasibility studies are defined as those aimed at evaluating (a) the 
recruitment method and sample characteristics, (b) the optimisation of the data collection method and measures, 
(c) the acceptability of the intervention, (d) the availability of resources, and finally (e) the preliminary 
assessment of responses to the intervention (see Orsmond & Cohn, 2015). Here, acceptability refers to a “multi-
faceted construct that reflects the extent to which people delivering or receiving a health-care intervention 
consider it to be appropriate, based on the anticipated or experiential cognitive and emotional responses to the 
intervention” (Sekhon, Cartwright, & Francis, 2017, p. 5). Thus, the current study was aimed at establishing the 
feasibility of conducting a large-scale randomised controlled trial of adapted-MBCT for people with depression 
and cardiovascular disorders. This includes: (a) evaluating the recruitment methods; (b) estimating the trial 
recruitment, eligibility and completion rates (e.g., percentage of eligible people taking part and the percentage of 
participants completing the trial); (c) evaluating the three-arm design, randomisation, inclusion criteria and the 
data collection procedures; (d) describing the data on primary and secondary outcomes using descriptive 
statistics; and (e) estimating the standard deviation for continuous outcome measures that will be used in the 
calculation of the sample size for the large-scale trial. Also, the study aimed to establish the acceptability of 
adapted-MBCT for people with depression and cardiovascular disorders. 
Method 
Participants 
Eligible participants were adults aged 18 and older with a cardiovascular disorder (heart condition, 
stroke or hypertension). Participants also needed to have either a history of clinical depression (major depression 
disorder, minor depression or dysthymia) and/or current minor depression with or without anxiety symptoms. 
We excluded those who met the criteria for a current episode of major depression disorder. Other exclusion 
criteria were co-morbid diagnoses of current substance dependence or abuse, organic brain damage, current or 
past psychosis, persistent antisocial behaviour, persistent self-injury and formal concurrent psychotherapy. Each 
participant received £10 as a token of appreciation for participating in the study every time (s)he completed the 
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assessments with the researcher (£30 maximum per participant). The sample characteristics of the participants in 
the three groups are described in Table 1. The mean (SD) age was 64.8 (10.0); 58 % were male; 61 % were 
married; and 94 % were white British or Irish. Approximately two thirds were suffering from heart conditions, 
one third had had a stroke, four people had hypertension and five had two or more cardiovascular disorders. 
Seventy-six percent (76 %) of the participants were not receiving any antidepressant.  
We calculated the sample size based on the assumptions that about 20 % of people with recent acute 
coronary diseases have major depression and a further 20 % have raised symptoms of depression that do not 
meet the diagnostic threshold. There are about 1,000 patients per year passing through the Exeter cardiology 
service following having experienced acute coronary diseases. The aim was to recruit for seven months and 
based on that we expected that approximately (a) 580 patients (7/12*1000) would pass through in that period; 
(b) 230 patients (40% of the 580) would have at least mild depression; (c) 92 patients (40 % of the 230) would 
participate in the study; and (d) 74 patients (80 % of the 92) would be followed up at 3 months (approximately 
24 per group, based on running two groups for each of adapted-MBCT and MBSR). The 580 patients with acute 
coronary diseases would be large enough to estimate the percentage with at least mild depression with a margin 
of error no greater than +/- 4 percentage points, based on the width of the 95% confidence interval. The 230 
patients with mild depression would be large enough to estimate the percentages that participate with a margin 
of error no greater than +/- 7 percentage points. The 92 trial participants would be large enough to estimate the 
percentage followed up at 3 months with a margin of error no greater than +/- 11 percentage points. The 74 
participants that provide data at 3 months' follow-up would be large enough to estimate the standard deviation 
for a continuous outcome to within 20 % of the true value. 
Procedures  
This project is a feasibility study of a three-arm randomised controlled trial comparing adapted-MBCT 
(HeLM) plus treatment as usual (TAU), standard mindfulness-based stress reduction (MBSR) plus TAU, and 
TAU alone, for the treatment of depressive symptoms in people with comorbid depression and cardiovascular 
disorders. For the purpose of feasibility, in this study we intended to draw out whether conducting a 3-arm 
design would be practicable or not. If we proceed to a main trial, we hope to compare MBCT-HeLM with 
MBSR to determine its relative efficacy on key primary and secondary outcomes. The study was conducted in 
the AccEPT Clinic/ Mood Disorders Centre at the University of Exeter. Participants completed a set of self-
report questionnaires and blood pressure was recorded at baseline, post intervention and at three-month follow-
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up. Those in the MBCT-HeLM group additionally took part in a short qualitative interview after completing the 
course to assess the acceptability of the adapted MBCT intervention. 
The recruitment process was conducted through three resources: primary care (GPs), specialised 
services (the cardiology department at Royal Devon & Exeter Hospital), and in the community in Exeter via 
distributed materials, with one objective being to assess the efficiency of these methods. Physicians and nurses 
in the cardiology department were invited to inform in/outpatients about the study and the outpatient’s clinic 
nurses were asked to screen interested patients using Patient Health Questionnaire-8 (PHQ-8). This tool contains 
eight of the nine items of Patient Health Questionnaire-9 (PHQ-9) designed to evaluate major depressive 
disorder (MDD), as defined by the criteria stated in the Diagnostic Statistical Manual of Mental Disorders-
Fourth Edition (DSM-IV). This brief version of the PHQ-9 has shown good validity and reliability for a general 
population (Kroenke et al., 2009) as well as for people with depression and heart conditions (Pressler et al., 
2011). We chose to use this version excluding the suicide ideation or attempts item, as we anticipated delivering 
some of these questionnaires by post and we considered that this version might be more acceptable to patients 
completing the assessment in the absence of any researcher or clinician on hand to respond to any immediate 
concerns. We also added a question to assess whether the patient had a history of depression (no specific 
number of episodes) either after or before cardiovascular disorder onset. If a patient had a score between 5 and 
15 (minimal to moderate depression) according to PHQ-8 cut offs or had a history of depression, (s) he received 
a copy of a poster containing a brief description of the study and a summary information sheet. GPs were also 
invited to refer suitable patients to the study. They were asked to identity patients registered at their surgery 
against the study's inclusion and exclusion criteria. Following this, patients were sent letters from the GP with a 
summary information sheet, which informed potentially eligible people that they could contact the researcher by 
post using the free-envelope, telephone or e-mail. In addition, posters containing information on the study were 
distributed in cafés and restaurants; the posters were put on tables so potential participants could take one. 
All interested people were contacted by telephone and screened after providing verbal consent. The full 
information sheets were sent to all eligible people by post. Subsequently, they were invited to an initial interview 
with the lead researcher (MA), to have the study explained further and to ensure they met the study inclusion 
criteria, using the structured clinical interview for DSM-IV-TR (SCID-I) (First, Gibbon, Spitzer, & Williams, 
2002). In this study, we used some parts of the mood episodes section (current major depressive episode (MDE), 
past MDE and current dysthymic disorders) in order to assess a potential participant’s eligibility in detail. In this 
interview, informed written consent was obtained from all the participants and the baseline assessment was 
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administered using questionnaires. In addition, each participant’s blood pressure was measured using an automatic 
blood pressure monitor. The first screen was conducted during the first four months of the recruitment to check 
the inclusion/exclusion criteria of the study by MA and RV. The second was undertaken two weeks prior to the 
baseline by MA. During this phase, we checked current depression in people who were found eligible in the first 
screen. The reason for conducting two screens was that we thought four months duration of recruitment (the period 
between initial recruitment and randomisation) was a relatively long period of time for checking current 
depression and we wanted to make sure that people still wanted to take part so as to minimise drop out post 
randomisation. 
Participants were randomised using sealed envelopes to conceal allocation. Blocking was used with 
randomly permuted block sizes in a non-systematic sequence. Randomisation of participants was stratified to 
ensure balance between the three trial arms based on severity of depression (based on PHQ-9 cut-off) and type of 
cardiovascular disorder (heart conditions, stroke and hypertension). The randomisation process was conducted by 
an independent researcher after the baseline assessment. It was not possible for the lead researcher (MA) to be 
blind at the post-intervention and follow up assessments. Participants were informed about their allocation status 
by post and those in the MBCT-HeLM and MBSR groups were asked to provide convenient times for meeting 
the mindfulness therapist (AE) for a one-hour orientation session before starting the intervention.  
The MBCT-HeLM manual was developed across three stages and included two pilot MBCT groups 
with people with depression and CVDs. During the first stage of the manual development, seven monthly 
meetings were held between HeLM project’s members with expertise in mindfulness interventions and people 
drawn from a Patient and Public Involvement (PPI) group, who had cardiovascular problems (January to July 
2013). Some of the people with CVD also had co-morbid mood disorders. Through these meetings, the original 
MBCT manual was reviewed and the best ways to make it more appropriate for people with cardiovascular 
disorders were discussed in detail. For the second stage of developing the manual, a pilot group was conducted 
in July/Aug 2013 using the first draft of the manual. The group comprised four members of the HeLM project 
team (WK, CD, AE and RV) as well as people from the PPI group and eight further participants with depression 
and CVD. The aim in conducting this group was to identify any changes to the manual that were necessary 
through discussions amongst the HeLM members, PPI group and people with cardiovascular disorders on a 
week by week basis throughout the course. In the third stage of developing the manual, we conducted a second 
pilot group in October/Nov 2014 using the MBCT manual incorporating learning from phase 2. Weekly 
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meetings were held after each MBCT session between the therapists (WK and AE) and the lead researcher (MA) 
to discuss the manual.  
Participants were assessed at three-time points: a baseline assessment conducted three weeks prior to 
randomisation; a post-intervention assessment taking place at the end of the MBCT-HeLM and MBSR groups; 
and a three-month follow-up after the interventions completion to examine maintenance of any gains achieved. 
For the TAU group, all assessments were at the same point post-randomisation. The lead researcher (MA) 
conducted the assessments at face-to-face meetings with the participants. 
Interventions 
Adapted-MBCT (HeLM). Mindfulness-Based Cognitive Therapy (MBCT) is a programme outlined 
by Segal et al. (2002, 2013) and developed based on Mindfulness-Based Stress Reduction (MBSR). It comprises 
an individual orientation session and eight weekly 2.5-hour group sessions. MBCT entails extensive 
mindfulness practices as well cognitive-behavioural exercises. It is designed to help people become aware of 
problematic styles of thinking and reacting, to decentre from these and respond more adaptively at times of a 
potential depressive relapse. The MBCT-HeLM manual maintained the essential structure and content of the 
original MBCT manual, but the focus and themes were reoriented to those that characterise people with low 
mood and CVDs. For example, in the first half of the programme participants were oriented to turning towards 
bodily experiences associated with CVD, with curiosity, friendliness and care. Instead of an exclusive focus on 
depressive thinking, the emphasis was shifted to the ways in which physical symptoms were interpreted, for 
example, ‘catastrophic thinking’. In session 4, the focus was on how stress/low mood/anxiety relates to bodily 
experience in a reciprocal relationship. We used the RAIN acronym (Recognise, Allow, Inquire and thoughts 
are Not facts). The first stage involves recognising when distressing bodily sensations, thoughts and images and 
feelings arise. Over time the intention is to support an ability to decentre and disengage from problematic ways 
of reacting and learn to respond with greater understanding and compassion.  In session 5, the title of the session 
was changed to ‘Softness and Strength’. In this session, the RAIN acronym progresses to participants being 
invited to turn towards difficulties with a sense of allowing and inquiry. In this session, the themes around 
fear/hyperarousal or sadness/loss are picked up more fully with a view to beginning to decentre clearly from 
proliferation and over-identification. In session 6, the title of the session was changed to ‘Symptoms as 
messages from the body; thoughts are not facts’. In this session, the RAIN acronym progresses to Inquiry and 
‘thoughts are not facts’. The intention is to recognise, allow and decentre from fear-based thinking/imagery, 
sadness/loss and proliferative thinking through dis-identification with these habitual patterns of reacting. This 
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session also includes beginning to note the possibility of responding compassionately with discernment / 
wisdom. Throughout the programme there was a greater emphasis on mental and physical self-care. Participants 
were asked to complete a daily home practice dairy six day per week, and they were given mindfulness CDs to 
guide this practice. They were also invited to a long-day practice after Session 6 to make sure that those in both 
groups were receiving the same dose of MBCT-HeLM and MBSR. The participants were asked to continue with 
treatment as usual (their normal clinical care). After completing the study, all the MBCT-HeLM participants 
were invited to regular reunion sessions in the AccEPT Clinic/ Mood Disorders Centre at the University of 
Exeter.  
Standard MBSR. Mindfulness-Based Stress Reduction (MBSR; Kabat-Zinn, 1990, 2013) consists of 
eight weekly 2.5 hours sessions with up to 30 participants and includes a full day of practice. MBSR comprises 
extensive formal and informal mindfulness-based exercises (e.g., body scan, breathing awareness, mindful yoga, 
mindful eating and mindful walking). The intention is to develop awareness and a new relationship with 
experience characterised by present moment focus, approach orientation, compassion, understanding and 
equanimity. Participants were asked to complete a daily home practice dairy six day per week, and they were 
given mindfulness CDs to guide this practice. They were also asked to continue with treatment as usual (their 
normal clinical care). After completing the study, all the MBSR participants were invited to regular reunion 
sessions in the AccEPT Clinic/ Mood Disorders Centre at the University of Exeter. 
Treatment as usual (TAU). In this group, the participants were asked to continue their normal clinical 
care. Treatment as usual (TAU) could include psychiatric treatment, outpatient consultation, routine visits to the 
GP and support programmes from the mental health or cardiac nurse. These participants were offered standard 
MBCT service AccEPT Clinic at the Mood Disorders Centre after completing the follow up assessment.   
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Outcomes 
The feasibility of MBCT-HeLM intervention in people with depression and cardiovascular disorders 
was established based on recruitment (recruitment methods, screening and baseline phases), retention rate 
(course completion), attrition rate (dropouts), participants’ adherence (attendance, home practice and assessment 
completion) and other procedures, including randomisation, therapist adherence, inclusion/exclusion criteria and 
outcome measures. The rate of recruitment was quantified by the percentage of eligible people that were 
recruited and randomised. Retention and attrition were assessed by determining the percentage of completers 
and dropouts. The participants’ adherence was measured using attendance rate and total time spent on the home 
mindfulness practice. In terms of assessment completion, we measured the percentage of people who fully 
completed each outcome assessment in each of the three groups.  
We developed a short interview schedule with questions focusing on the MBCT-HeLM participants’ 
overall satisfaction with the study, their views regarding the MBCT-HeLM techniques, home practice, the group 
format, and the physical and psychological advantages/ disadvantages from having taken part. The interviews 
were carried out face-to-face at the Mood Disorders Centre/University of Exeter. All the people who completed 
the MBCT-HeLM course were interviewed. In addition, those who dropped out were asked about their overall 
experience with the study and their reasons for dropping out. Each interview was audio recorded and took 
between 15 and 25 minutes, being subsequently transcribed verbatim by a transcription service. The home 
practice record sheet was used to assess which mindfulness practice participants were completing it and the 
amount of time spent on practice each week. Participants in the MBCT-HeLM and MBSR groups were asked to 
complete this sheet each week throughout the course and return it to the mindfulness teacher. The lead 
researcher photocopied the sheet and they were returned to the participants the following week.  
The primary outcome was depression symptoms. Secondary outcomes were physical health related, 
including blood pressure, which is considered to be an important risk factor for developing a cardiovascular 
disorder (Kelly & Fuster, 2010) and heart-focused anxiety (HFA), which has been found to be linked to 
increased anxiety, depression and lower quality of life among people undergoing cardiac surgery (Hoyer et al., 
2008). Further secondary outcomes, are illness perceptions (participants’ beliefs about their illness), which are 
associated with the speed and quality of recovery after myocardial infraction (Petrie, Weinman, Sharpe, & 
Buckley, 1996) and general and specific quality of life in people with cardiovascular disorders, which are 
considered to be important indicators of the effectiveness of any treatment in people with heart disorders 
(Thompson & Yu, 2003). Additionally, we used three process measures that we might use in a definitive trial to 
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examine hypothesised mechanisms of action in MBCT-HeLM: mindfulness, self-compassion and positive and 
negative affect. These processes have been identified as mediators of outcome in previous studies of MBCT 
(Geschwind, Peeters, Drukker, van Os & Wichers, 2011; Kuyken et al., 2010; Shahar, Britton, Sbarra, 
Figueredo, & Bootzin, 2010). Also, mindfulness has been found to be a mediator of the effects of MBCT in 
people with coronary heart diseases (O’Doherty et al., 2015).  
Measures  
Depression. Depressive symptoms were assessed using Patient Health Questionnaire-9 (PHQ-9; 
Spitzer, Kroenke, Williams, & Group, 1999), which contains nine items reflecting Diagnostic Statistical Manual 
of Mental Disorders-Fourth Edition (DSM-IV) criteria of major depression disorder (MDD). Each item is scored 
between 0 and 3 with, a range of total scores between 0 and 27. The cut-off points of PHQ-9 are 5, 10, 15, and 
20, which define the following levels of severity: none/minimal depression (0-4), mild depression (5-9), 
moderate depression (10-14), moderately severe depression (15-19), and severe depression (20-27). PHQ-9 has 
been found to have adequate psychometric properties in the UK (Cameron, Crawford, Lawton, & Reid, 2008) as 
well as in people with coronary heart disease (Haddad et al., 2013).  
Blood pressure. Levels of blood pressure in each participant were recorded using an Advanced 
Clinically Validated Blood Pressure Arm Monitor, which provides readings of systolic and diastolic blood 
pressure.  
Generalised Anxiety. Severity of general anxiety symptoms was assessed using Generalised Anxiety 
Disorder-7 (GAD-7; Spitzer, Kroenke, Williams, & Lowe, 2006). This questionnaire comprises seven items 
reflecting the DSM-IV criteria of generalised anxiety disorder (GAD). Each item is rated between 0 and 3 with, 
a range of total scores between 0 and 21 with four levels of severity: none (0-4), mild anxiety (5-9), moderate 
anxiety (10-14), and severe (15-21). GAD-7 has been found to have good reliability and validity (Spitzer et al., 
2006).  
Cardiac anxiety. The Cardiac Anxiety Questionnaire (CAQ; Eifert et al., 2000) was used to assess 
heart-focused anxiety (HFA). The CAQ is a self-report containing 18 items reflecting three clinical aspects: 
cardio-protective avoidance behaviour, heart-focused attention and fears about heart sensations. Each item is 
scored from 0 (never) to 4 (always) with a range of total scores between 0 and 72. Higher scores indicate greater 
heart-focused anxiety (HFA). The CAQ has been found to have good internal consistency (Eifert et al., 2000). In 
current study, this questionnaire was used with people with heart conditions only.  
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Health-related quality of life. The RAND 36-Item Health Survey 1.0 (Hays, Sherbourne, & Mazel, 
1993) was used to assess the participants’ general quality of life. It contains 36 items, covering eight domains: 
physical functioning (PF), role-physical (RP), bodily pain (BP), general health (GH), vitality (V), social 
functioning (SF), role-emotional (RE) and mental health (MH). These domains can be grouped into two main 
components: physical and psychological. Each item is recoded on a 0 to 100 range and then an average of the 
scores for the items in each domain is obtained, with higher scores being consonant with greater functioning and 
enhanced well-being. The RAND 36-Item has been found to have good psychometric properties (Hays, 
Sherbourne, & Mazel, 1995).  
Health-related quality of life in people with cardiac problems. The Seattle Angina Questionnaire 
(SAQ; Spertus et al., 1995) is a specific measure that has been widely used to assess the health outcomes in 
people with angina. It contains 19 items, covering five clinical dimensions (subscales): physical limitations, 
angina stability, angina frequency, treatment satisfaction and disease perception. Each subscale is scored by 
reordering each response, summing up the scores for each subscale and then transforming the scores to a range 
0-100. No actual total for SAQ could be obtained, but those with higher scores indicate high levels of health and 
satisfaction. The SAQ has shown good validity and reliability in the UK (Garratt, Hutchinson, & Russell, 2001). 
In the HeLM study, we used this questionnaire with people with heart conditions only. 
Illness perception. The Illness Perception Questionnaire-Revised (IPQ-R; Moss-Morris et al., 2002) 
was used to assess participants’ beliefs about their illness. This measure is a revised version of the illness 
perception questionnaire (IPQ) that was developed to assess cognitive representations. The IPQ-R measure 
comprises three sections; the first and third sections are called identity and causality. The second section 
contains 38 items covering seven dimensions: timeline acute/chronic, timeline cyclical, consequences, personal 
control, treatment control, illness coherence and emotional representations. In the HeLM study, we used the 
second section with the 38 items, each being rated between 1 and 5. The IPQ-R was scored by reversing some 
items and then summing up scores for each of the seven dimensions. No total for IPQ-R could be obtained. The 
IPQ-R measure has been used with people suffering from heart diseases and has showed good psychometric 
properties in the UK (Moss-Morris et al., 2002).  
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Mindfulness. The Five-Facet Mindfulness Questionnaire (FFMQ; Baer, Smith, Hopkins, Krietemeyer, 
& Toney, 2006) was designed to assess different aspects of mindfulness. It consists of 39 items, reflecting five 
facets: non-reactivity to inner experience (7 items), observing (8 items), acting with awareness (8 items), and 
describing (8 items) and non-judging of experience (8 items). Each item is rated on a 5-point Likert scale 
ranging from 1 (never or very rarely true) to 5 (very often or always true). The questionnaire is scored by 
reversing some items and then summing up the scores for each of the five facets. The total FFMQ score is 
obtained by summing up the five facet scores. The FFMQ has been found to have good psychometric properties 
(Baer et al., 2008; Baer et al., 2006). 
Self-compassion. The Self-Compassion Scale (SCS; Neff, 2003) is a measure assessing the overall 
compassion according to three components: self-kindness, common humanity and mindfulness. Each component 
has a negative aspect: self-judgment, isolation and over-identification, respectively. It contains 26 items that are 
rated on a Likert scale from 1 (almost never) to 5 (almost always). The SCS subscales are scored by calculating 
the mean of responses on each subscale. The total SCS is scored by reversing scores of the negative subscales 
(self-judgment, isolation, and over-identification) and then computing a mean of the subscale means. The SCS 
has been found to have good validity and reliability across different cultures (Neff, 2003).  
Positive and negative affect. The Positive and Negative Affect Scale (PANAS; Watson, Clark, & 
Tellegen, 1988) was used to assess participants’ mood. It comprises 20 items that can be used to evaluate one’s 
mood at various times-points. The items are rated using a Likert scale from 1 (very slightly) to 5 (extremely). 
The positive affect subscale is scored by adding the scores of items 1, 3, 5, 9, 10, 12, 14, 16, 17, and 19. The 
negative affect subscale is scored by adding the scores of items 2, 4, 6, 7, 8, 11, 13, 15, 18, and 20. The PANAS 
has shown good validity and reliability in the UK (Crawford & Henry, 2004).  
Therapist Adherence and Competence  
Both the MBCT-HeLM and MBSR groups were conducted by a trained and experienced mindfulness–
based therapist (AE) with a considerable length of practice. The therapist received weekly supervision from an 
independent supervisor. The group sessions were video-recorded, and an independent mindfulness therapist 
evaluated two MBCT-HeLM and two MBSR sessions for competence and adherence. The Mindfulness-based 
Intervention: Teaching Assessment Criteria (MBI: TAC) (Crane et al., 2013), which is rated on a scale from 1 
(incompetent) to 6 (advanced), was used. 
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Data Analyses 
The data were analysed in line with the guidelines for good practice in designing, analysing and 
reporting pilot and feasibility studies (Lancaster, Dodd, & Williamson, 2004; Lancaster, 2015). The percentage 
of eligible people that consented to participate is reported with 95 % confidence intervals. Similarly, the 
percentage of the participants that provided follow-up data and the percentage of those in the MBCT-HeLM and 
MBSR arms that completed the interventions are reported. The characteristics of the participants in each trial 
arm are summarised using means and standard deviations for continuous variables and percentages for 
categorical ones. Given the study aims were to assess the feasibility and acceptability of MBCT-HeLM, but not 
testing hypotheses, we report the quantitative results in a descriptive way. We provide 95 % confidence 
intervals, which illustrate the amount of uncertainty there is regarding the true intervention effect. For each of 
the primary and secondary outcomes, we used the means, standard deviations (SDs), mean differences and 95 % 
confidence intervals between the groups. For the process measures, we used a similar method of using the 
means, standard deviations (SDs), mean differences and 95 % confidence intervals between the groups. 
Regarding the qualitative analysis, the NVivo programme was employed to help with coding the data. We used 
the thematic analysis method with the six phases suggested by Braun and Clarke (2006) in order to analyse the 
interviews. 
Results 
The results of the study are reported according to guidelines for good practice in designing, analysing 
and reporting pilot and feasibility studies (Lancaster, Dodd, & Williamson, 2004; Lancaster, 2015). In addition, 
we used the Consolidated Standards of Reporting Trials (CONSORT) extension guidelines for reporting pilot 
and feasibility studies (Thabane et al., 2010). The first aim of this study was to establish the feasibility of 
conducting a randomised controlled trial of MBCT-HeLM in addition to TAU vs. MBSR along with TAU vs. 
TAU alone. In general, the results indicate that there are several positive indicators about the feasibility, with the 
main challenge being recruitment.  
Recruitment Rate 
Three methods of recruitment (GPs, cardiology department at Royal Devon and Exeter hospital and 
advertisement) were used in the HeLM feasibility study. The recruitment and screening phases were conducted 
over four months (July to October 2014). Invitations were sent to 3,340 people through three GPs (two in Exeter 
and one in Exmouth), while a summary of the study was handed to 50-60 patients out of approximately 144 
patients passing through the outpatients’ clinic for about 12 weeks by the cardiac nurses in the cardiology 
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department. This was different to our calculation of the sample size as we estimated that 82 patients would pass 
every month (250 for the 12 weeks). In addition, 600 copies of a study poster were distributed in nine cafés and 
restaurants in Exeter city centre, three weeks before the recruitment ended.  
As shown in the CONSORT diagram (Figure 1), of the 3,340 people approached through GPs, 239 
people (7.1%) were interested, 180 people (5 %) showed no interest (i.e. People who sent the reply form back to 
the researchers stating that they were not interested in the study) and the remainder (88 %) did not respond to 
the letters (i.e. People who did not send the reply form back to the researchers). Regarding the cardiology 
department, we had three interested people (5 % of the 60 people who were approached through the cardiology 
department) and no individuals responded to the advertisements. During the first screen, 183 out of the 242 
interested people (76 %) were excluded for the following reasons: no low mood as people reported (n = 99), no 
cardiovascular disorder (n = 20), not interested anymore (n = 15), could not attend the group dates (n = 20), non-
contactable (n = 12) and other reasons (n = 17). This resulted in 59 out of the 3,340 approached people (1.7 %) 
meeting the criteria of the first screen. For the second screen, two people were excluded, as they had current 
major depression, another one was non-contactable and 15 did not wish to continue the study. The reasons for 
withdrawing were health (n = 8), family (n = 2), work (n = 3), or holding the view that the mindfulness course 
did not seem right for them (n = 2). In the baseline phase, 41 people who met the study criteria were invited to a 
diagnostic interview where the SCID was applied to check for past and current major depressive disorder 
(MDD), minor depression as well as dysthymia. In this phase, three people were excluded, as two had current 
major depression and one was misusing drugs. Two people quit for health reasons (they had shortness of breath 
and found it hard to come to the Mood Disorders Centre/ Exeter University) and three did not show up (one of 
them could not come as he had a cardiac problem). Finally, 33 out of the 59 eligible people (56%; 95% CI: 43% 
to 68%) gave their consent and were randomly allocated to the three groups: MBCT-HeLM (N = 11), MBSR (N 
= 11) and TAU (N = 11). Given the total of the sent invitations comprised 3,340 letters and summaries, this 
meant we managed to recruit only 1.0% (95% CI: 0.7% to 1.4%) of these. In the orientation sessions, one 
participant from the MBSR group was excluded from the study, as it was agreed that her chest pain was stress-
related and not a cardiovascular disorder. As this woman had recurrent major depression, she was referred to the 
AccEPT Clinic for standard care. No difficulties were noticed regarding running the groups or collecting data. 
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Retention and Attrition Rates  
Seven of the 11 participants (64 %; 95 % CI: 36 % to 86 %) in the MBCT-HeLM group completed the 
course. Of those who dropped out, three could not make the scheduled group times, two found it hard to alter 
their work times and one had a severe chest infection. After the third session, one woman dropped out for family 
reasons. Regarding the MBSR group (n = 10), six people (60 %) started and after the second session of MBSR, 
a woman dropped out as she said that it was hard for her to complete the home practice and come to the Mood 
Disorder Centre/University due to her serious physical disability caused by a stroke. The other people (n = 4) 
could not attend the group dates; one participant got a new job, one participant had to babysit a child, one had 
had a surgery and one did not attend due to work-related issues.  
Participants Adherence  
In the MBCT-HeLM group, seven out of the eight people who took part attended between six and eight 
sessions, while one woman only attended two. In the MBSR group, of the six who took part, four attended eight 
while one attended seven sessions and one woman attended two. Regarding the full-day mindfulness practice, 
six people from the MBCT-HeLM and five from the MBSR groups attended. We asked the MBCT-HeLM 
group to practise some formal and informal exercises at home for six days per week so as to integrate 
mindfulness into their daily life. Five out of the seven people who completed the course provided five out of the 
seven home practice sheets and two completed three. The average amount of practice was 5 days per week. 
Regarding assessments completion, twenty-nine out of the 33 participants randomised into the trial (88 %; 95 % 
CI: 77 % to 98 %) completed the assessment at post-intervention and at the 3-month follow-up phase. All 
participants in the MBCT-HeLM (n = 11) and MBSR (n = 10) groups completed the post-intervention and 
follow-up assessments, whilst three from the TAU group (n = 11) did not.   
Therapist Adherence and Competence  
For therapist adherence and competence, we used the Mindfulness-based Interventions: Teaching 
Assessment Criteria (MBI: TAC), which is rated on a scale from 1 (incompetent) to 6 (advanced), with the 
average rating being 5 (proficient) for both the MBCT-HeLM and MBSR.  
Describing the Primary and Other Outcomes Data  
Table 2 shows the clinical characteristics at baseline for all the study outcomes. Regarding the study 
primary outcome, Table 3 shows the PHQ-9 means, SDs, mean differences and 95% confidence intervals for 
MBCT-HeLM vs. MBSR and MBCT-HeLM vs. TAU at post-intervention and at three-month follow-up. The 
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mean PHQ-9 scores for the MBCT-HeLM group was 0.2 (CI: -3.4 to 2.9) lower at post-intervention and 1.4 (CI: 
-3.8 to 1.0) lower at three-month follow-up, than for the MBSR group. The MBCT-HeLM mean was 2.3 (CI: -
7.2 to 2.5) lower at post-intervention and 5.2 (CI: -8.5 to -1.8) lower at the three-month follow-up compared to 
the TAU group. With regards to secondary and process outcomes, Tables 4 and 5 summarise the means, SDs, 
mean differences and 95% confidence intervals across the three groups at post-intervention and three-month 
follow-up for the study’s secondary and process outcomes. The mean GAD scores for the MBCT-HeLM and 
MBSR groups was lower at post-intervention and at three-month follow-up compared to the TAU group. The 
mean RAND 36-Item (psychological domain) scores for the MBCT-HeLM and MBSR groups were higher at 
both post-intervention and at three-months follow-up than for the TAU group, while the mean RAND 36-Item 
(physical domain) for the MBSR group was higher at three-months follow-up compared to both the MBCT-
HeLM and TAU groups. The means of some of the IPQ-R subscales (timeline acute, emotional representations 
and consequences) for the MBCT-HeLM group were lower at both post-intervention and at three-months 
follow-up than for the MBSR and TAU groups, while those for the personal and treatment control subscales of 
IPQ-R for MBSR were lower than the means of the MBCT-HeLM and TAU groups. The mean FFMQ for 
MBCT-HeLM was 4.0 higher than for the MBSR and 18.0 higher than for the TAU group, at post-intervention 
assessment, whilst it was 6.0 lower than for the MBSR group and 10.0 higher than for TAU, at the follow up 
assessment. Regarding SCS, both the MBCT-HeLM and MBSR means were higher than for the TAU group at 
both time-point assessments. Finally, the mean of PANAS-Positive was higher for the MBSR group compared 
to the other groups at both time-point assessments.    
The Acceptability Interviews 
The second aim of this study was to see how acceptable MBCT-HeLM was for people with depression 
and cardiovascular disorders. Those who completed the MBCT-HeLM course (six people with heart conditions 
and one participant with stroke) described it and their overall experience as enjoyable; considering it different to 
other psychological programmes that they had in the past; finding it flexible and helpful. They had joined the 
course with the expectation that it would help in controlling physical symptoms, such as high blood pressure and 
heart complaints as well as understanding depression and making them calmer. Participants felt that the course 
had met some of their expectations in terms of understanding depression and seeing things in a different way, 
but less in terms of managing physical symptoms. They reported that the one-to-one orientation session was 
helpful in terms of understanding the content of course. They generally agreed that eight sessions represented a 
good course length, in that they thought that they needed time to understand mindfulness and to integrate it into 
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their daily life and two of them felt that the course needs to be more than eight sessions. All seven participants 
said that the 3-Step Breathing Space exercise was the most useful and four of them found the Body Scan 
helpful. Participants described some challenges with the MBCT-HeLM course, in particular, being in a group 
and making the course a priority in their lives. Additional feedback is summarised in Table 6. 
Discussion 
The first aim of the HeLM study was to establish the feasibility of conducting an adequately powered 
randomised controlled trial of MBCT-HeLM for people with depression and cardiovascular disorders. The 
second aim was to assess how acceptable this course was to the participants. No prior statistical criteria of 
success have been set up for this study and instead, we have compared our results with those of other studies 
that used MBCT or MBSR for people with depression and/or CVDs. The results were encouraging in terms of 
MBCT-HeLM’s acceptability and participants’ engagement with the course. However, the large funnel between 
potentially eligible participants and those who participated in the trial suggests serious challenges with regard to 
recruitment to such a trial.  
Recruiting through GP practices was the most useful resource of the three methods used, accounting 
for 239 people (99 %) of all interested people. However, the percentage of those who replied to the invitation 
letters was only 1 %, which means that the future definitive trial will need to invite 1,000 people to get 10 
consenting participants. This is less than reported for other MBCT trials (e.g., Kuyken et al., 2016; 2 %). While 
recruiting to clinical trials is a challenge for many areas of research, this may be especially so for mental health 
ones (Barton, 2000; TenHave, Coyne, Salzer, & Katz, 2003), despite the high prevalence rates of mental health 
problems. In addition, there is limited access to evidence-based treatment. Recruitment through specialist CVD 
services was not successful (Figure 1). Cardiac nurses are typically very busy and triaging to this study added to 
their busy schedules. Moreover, people who visit cardiac wards often attend with unstable conditions and are 
not in a position to consider taking part in a psychosocial intervention like MBCT or MBSR. Moreover, direct 
advertising did not yield any responses.  
The screening procedures worked well (Figure 1). In addition, conducting a second screen enabled a 
further check on eligibility before moving to baseline assessment. However, in the first screen, the way to 
ascertain whether people were suffering from depression was mostly based on asking them a few questions 
about their history of depression. In future studies, it would be beneficial to use an in-depth screen in the early 
stage of recruitment, which could capture the history of depression in detail and might increase the eligibility 
rate. During the orientation sessions, one female participant was excluded due to uncertainty as to whether she 
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was suffering cardiac problems or stress-related chest pain. In this study, the evaluative process to determine the 
presence of a cardiovascular disorder was based on the self-reporting of the participants. In future studies, an 
alternative method of determining a person’s condition should be used, such as obtaining a clinical diagnosis 
from a potential participant’s healthcare professional.  
The initial drop-out rates were relatively high as 9 of the 21 (42%) randomised people in the MBCT 
and MBSR groups could not attend the group dates. The drop-out rate reported in this study is similar to that in 
the MBCT study conducted by O’Doherty et al. (2015) in people with coronary heart diseases as they had 47% 
drop-out rate. Specifically, only 32 out of 60 people in the MBCT group and 30 out of 57 people in the control 
group completed the study. In a non-controlled study (Olivo, Dodson-Lavelle, Wren, Fang, & Oz, 2009) using a 
shortened MBSR course with people with coronary heart diseases (n = 35) the drop-out rate reported was only 
11 % (n = 4), which is lower than ours. However, those two studies (O’Doherty et al., 2015; Olivo et al., 2009), 
targeting mindfulness and heart conditions used non-randomised or non-controlled designs. In addition, the 
study by (O’Doherty et al., 2015) recruited people and conducted the interventions over approximately three 
years, while that by (Olivo et al., 2009) used a short intervention (4 MBSR sessions). In our study, the reasons 
given for withdrawing and dropping out varied, but health issues was the most common one provided. Research 
concerning elderly populations indicates that older people report higher chronic physical symptoms (Naylor et 
al., 2012) and therefore, it might be useful to consider delivering MBCT in ways and locations that are more 
convenient for this population. The second most common reason was work commitments, suggesting that it is 
important to consider the timing of MBCT sessions, which could lead to an increase in the participation rate in 
future studies. In sum, the need to enhance the accessibility of any psychosocial intervention for this group is 
evidenced. 
With regards to course completion, attendance and home practice, this study attained good rates of 
compliance. Of those people who did engage with MBCT-HeLM, they attended most sessions and engaged with 
the mindfulness practice throughout the course. This suggests that of the sub-group who do attend, the course is 
acceptable. The 3-Step Breathing Space and Body Scan seemed to be the most important practices. Regarding 
assessment completion, the study had a good rate as the majority of participants completed the questionnaires at 
the post-intervention and follow-up phases, which indicates that the measures employed were acceptable to 
them. This completion rate is relatively similar to those reported in other mindfulness studies with heart 
conditions (O’Doherty et al., 2015; Olivo et al., 2009). The randomisation and stratification process were 
successful, which can be concluded because the main characteristics baselines were similar in the three groups. 
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There was significant sample heterogeneity in terms of whether the sample was currently depressed (minor 
depression) or had a history of depression as well as regarding the time since the cardiac event (heart attack or 
stroke) and the onset of cardiovascular disorders. Importantly, there was significant heterogeneity regarding 
whether depression had happened before or after a CVD.  
Participants who engaged with MBCT-HeLM reported a good satisfaction level with the course in 
terms of its content, exercises, home practice and completion of the measures. The majority of them found the 3-
Step Breathing Space and Body Scan helpful. Being in a group was a challenge for some, although others said 
that it was helpful in terms of seeing how they were lucky compared to others. The participants’ challenges in 
this course were mainly about how to make it a priority. Regarding the quantitative results, it is important to 
emphasise that we did not set out to establish effectiveness, nor was it sufficiently powered to do so. Moreover, 
the wide confidence intervals illustrate the imprecision with which the intervention effects are estimated. 
Summary and Recommendations for the Definitive Trial  
To summarise, to our knowledge, this is the first randomised controlled trial with three arms aimed at 
understanding the issues surrounding the feasibility and acceptability of delivering MBCT for people with 
depression and cardiovascular disorders. This study provides some methodological considerations for future 
studies, such as the use of the 3-arm design, randomisation and blindness, as well as rates of recruitment, 
retention, attrition and participants’ adherence. We have demonstrated that an MBCT-HeLM course was 
feasible and acceptable to people who took part in the study. The number of people who were randomised 
(n = 33), despite the short period of recruitment (4 out of the 7 months that we planned in early stage of the 
study), was good. Moreover, retention and engagement rates were encouraging. However, the pool of potentially 
eligible participants was much larger and suggests some key barriers to the accessibility of an intervention such 
as MBCT, as well as to a trial such as this. Regarding the participants’ feedback on the study in relation to the 
course content, home practice and assessments, this was broadly positive.  
In any definitive trial, further effort should be given to recruiting a more representative sample in terms 
of targeting people with depression and cardiovascular disorders. It would also be useful to maximise the 
accessibility of the intervention through, for example, offering the course in appropriate places for interested 
people as well as offering evening classes that would suit those in full time employment. Also, it is worth 
considering introducing MBCT/MBSR to participants who are inpatients on cardiology wards. In addition, 
using a detailed screen for depression in the early stages of the recruitment process might lead to an increased 
eligibility rate. When people are provided with group dates prior to randomisation to check to see whether they 
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are available, which improves engagement and retention. With regards to the length of follow up, in any future 
definitive randomised controlled trial, a longer follow-up period would be required. Finally, if the decision is 
made to move to a definitive trial, the study recruitment procedures will need to be revised in order to recruit a 
large enough sample. 
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Table 1 
Demographic characteristics 
 
Total 
(N = 33) 
MBCT-HeLM group 
(N = 11) 
MBSR group 
(N = 11) 
TAU group 
(N = 11) 
Age, mean (SD) 64.8 (10.0) 64.2 (11.6) 64.8 (10.6) 65.4 (8.4) 
Gender, n (%)     
 Male 19 (58 %) 5 5 9 
 Female 14 (42 %) 6 6 2 
Marital status, n (%)     
 Single 4 (12 %) 1 2 1 
 Married 20 (61 %) 6 6 8 
 Divorced 8 (24 %) 3 3 2 
 Widowed 1 (3 %) 1 0 0 
Ethnicity, n (%)     
 White British/Irish 31 (94 %) 10 10 11 
 White other 1 (3 %) 1 0 0 
 Asian British 1 (3 %) 0 1 0 
Employment Status, n (%)     
 Employed 10 (30 %) 4 4 2 
 Unemployed 2 (6 %) 1 0 1 
Retired 21 (64 %) 6 7 8 
Type of CVD, n (%)     
Heart conditions 18 (55 %) 6 5 7 
 Stroke 10 (30 %) 4 4 2 
 Hypertension 4 (12 %) 1 1 2 
 Not-specified 1 (3 %) 0 1 0 
Having more than one CVD, n (%) 5 (15 %) 0 3 2 
On antidepressant medication, n (%)     
 Yes 8 (24 %) 1 2 5 
 No 25 (76 %) 10 9 6 
 Note. TAU: Treatment As Usual; SD: Standard Deviation; CVD: Cardiovascular Disorders.  
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Table 2 
Clinical characteristics at baseline 
 MBCT-HeLM group  MBSR group  TAU group  
Mean SD  Mean SD  Mean SD 
Primary outcome         
 Patient Health Questionnaire-9 (PHQ-9) 8.4  4.8  8.5 4.6  7.0 5.0 
Secondary outcomes          
 Blood Pressure         
 Blood pressure / Systolic 126.7 10.5  142.3 21.8  128.5 21.3 
 Blood pressure / Diastolic 73.8  12.7  77.6 14.3  70.6 8.3 
 Generalised Anxiety Questionnaire-7 (GAD-7) 8.2   3.5  7.0 5.2  4.8 3.3 
 Cardiac Anxiety Questionnaire (CAQ) 17.0  9.1  22.2 8.6  34.0 13.6 
 RAND 36-Item Physical 53.3  18.2  43.0 24.3  59.1 31.5 
 RAND 36-Item Psychological 53.1   21.2  42.3 13.3  51.8 19.3 
 Five-Facet Mindfulness Questionnaire (FFMQ) 121.0 15.4  122.0 17.9  113.7 16.4 
 Self-Compassion Scale (SCS) 2.5 0.5  2.6 0.6  2.4 0.6 
 PANAS-Positive affect  30.3   7.5  27.4 5.9  25.3 9.4 
 PANAS-Negative affect  20.0   8.5  17.4 6.1  18.0 6.9 
 Illness Perception Questionnaire-Revised (IPQ-R)         
 IPQ-R timeline acute/chronic  20.9  7.1  23.6 4.5  25.7 4.4 
 IPQ-R timeline cyclical 11.7  5.1  10.6 3.4  11.0 5.2 
 IPQ-R consequences 17.1  5.1  20.3 6.9  20.2 3.9 
 IPQ-R personal control 22.1  4.9  22.2 4.6  19.9 5.4 
 IPQ-R treatment control 18.9  3.5  15.9 2.8  17.3 4.4 
 IPQ-R illness coherence 17.5  4.7  19.2 5.8  19.6 4.7 
 IPQ-R emotional representations 18.3  6.2  20.7 2.6  19.7 4.3 
 The Seattle Angina Questionnaire (SAQ)         
 SAQ- physical limitations 52.5  13.8  48.1 17.8  37.8 18.7 
 SAQ- angina stability 56.0  21.9  36.6 8.1  36.0 16.7 
 SAQ- angina frequency 70.5   11.5  70.6 14.8  58.0 27.0 
 SAQ- treatment satisfaction 59.8  17.0  62.3 10.1  68.0 13.8 
 SAQ- disease perception 52.1  20.6  47.8 19.2  43.8 28.6 
Note. TAU: Treatment As Usual; SD: Standard Deviation.  
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Table 3 
Comparison of PHQ-9 at post-intervention and follow-up 
Outcome  MBCT-HeLM 
(N = 11) 
Mean (SD) 
MBSR 
(N = 10) 
Mean (SD) 
TAU 
(N = 8) 
Mean (SD) 
 MBCT-HeLM vs. MBSR 
 
MBCT-HeLM vs. TAU 
Mean diff. 95% CI Mean diff. 95% CI 
Baseline  
 
        8.4 (4.8) 8.5 (4.6) 7.0 (5.0)       
Post-intervention   
 
6.1(3.1) 6.3 (3.6) 8.4 (6.3)  -0.2 -3.4 to 2.9  -2.32 -7.23 to 2.57 
3- months follow-up 3.8(2.5) 5.2 (2.4) 9.0 (4.1)        -1.4 -3.8 to 1.0  -5.20 -8.56 to -1.83 
Note. PHQ-9: Patients Health Questionnaires-9; TAU: Treatment As Usual; SD: Standard Deviation; CI: Confidence Interval.  
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Table 4 
Comparison of secondary outcomes at post-intervention 
Outcomes 
MBCT-HeLM 
(N = 11) 
MBSR 
(N = 10) 
TAU 
(N = 7) 
 
MBCT-HeLM vs. MBSR 
 
MBCT-HeLM vs. TAU 
Mean (SD) Mean (SD) Mean (SD)  Mean diff. 95 % CI  Mean diff. 95 % CI 
Blood pressure          
 Systolic blood pressure (mmHg) 130.4 (20.7) 143.8 (20.7) 129.8 (14.8)  -13.4 -42.5 to 15.7  0.6 -20.3 to 21.4 
 Diastolic blood pressure (mmHg) 73.2 (16.4) 76.5 (17.8) 73.5 (9.3)  -3.3 -24.2 to 17.7  -0.3 -15.9 to 15.3 
GAD-7 4.8 (4.8) 4.4 (2.8) 6.4 (3.9)  0.4 -3.6 to 4.4  -1.6 -6.2 to 3.0 
CAQ* 18.3 (14.3) 18.0 (1.4) 30.5 (13.6)  0.3 -16.5 to 17.2     -12.1 -33.1 to 8.8 
RAND 36-Item Health Survey 1.0            
 RAND 36-Item Physical 49.5 (15.3) 56.4 (28.1) 59.1 (32.7)  -6.9 -27.6 to 13.9  -9.6 -40.2 to 21.2 
 RAND 36-Item Psychological 55 .5 (19.1) 60.8 (14.6) 48.7 (23.7)  -5.3 -21.6 to 11.0  6.8 -14.7 to 28.3 
FFMQ (Total) 128.0 (18.0) 124.0 (18.3) 110.0 (6.7)  4.0 -15.6 to 23.4  18.0 2.1 to 33.3 
SCS (Total) 2.6 (0.6) 2.8 (0.8) 2.4 (0.7)  -0.2 -0.9 to 0.5  0.2 -0.5 to 0.8 
PANAS-Positive 25.3 (7.1) 32.7 (4.3) 28.2 (7.4)  -7.4 -13.6 to -1.3  -2.9 -10.6 to 4.7 
PANAS-Negative 18.7 (9.8) 16.3 (6.6) 19.4 (9.1)  2.3 -6.3 to 11.0  -0.7 -10.8 to 9.3 
IPQ-R          
 IPQ-R timeline acute/chronic 18.1 (3.6) 18.6 (2.8) 18.7 (6.7)  -0.5 -3.8 to 2.8  -0.6 -6.0 to 4.7 
 IPQ-R timeline cyclical 11.5 (4.0) 11.1 (3.2) 10.4 (4.4)  0.4 -3.4 to 4.3  1.1 -3.5 to 5.7 
 IPQ-R consequences 19.7 (6.2) 18.8 (5.3) 19.0 (6.1)  0.9 -5.0 to 6.6  0.7 -5.8 to 7.2 
 IPQ-R personal control 23.2 (3.7) 19.2 (3.9) 23.1 (4.8)  4.0 0.1 to 7.8  0.1 -4.4 to 4.5 
 IPQ-R treatment control 16.8 (2.2) 13.8 (4.2) 17.7 (2.4)  3.0 -0.4 to 6.5  -0.9 -3.4 to 1.7 
 IPQ-R illness coherence 20.3 (2.3) 16.5 (5.9) 18.8 (2.8)  3.8 -0.7 to 8.4  1.5 -1.3 to 4.3 
 IPQ-R emotional representations 17.5 (5.2) 19.3 (5.1) 18.1 (4.6)  -1.8 -7.2 to 3.6  -0.6 -6.0 to 4.8 
SAQ**          
 SAQ- physical limitations 43.8(19.2) 41.8(21.4) 41.9(5.3)  2.0 -25.7 to 29.7   1.9  -25.8 to 29.5 
 SAQ- angina stability 52.0(17.8) 60.0(20.0) 50.0(20.5)  -8.0 -35.7 to 19.8  2.0 -1.3 to 65.3 
 SAQ- angina frequency 68.1(13.3) 68.3(13.6) 45.8 (17.6)  -0.2 -18.8 to 18.2  22.3 -6.1 to 50.5 
 SAQ- treatment satisfaction 58.0 (18.5) 64.7(11.4) 65.0 (11.9)  -6.7 -29.2 to 15.8  -7.0 -36.8 to 22.8 
 SAQ- disease perception 50.6 (23.4) 58.6(12.8) 44.4 (27.7)  -8.0 -35.5 to 19.5  6.2 -38.3 to 50.8  
Note: TAU: Treatment As Usual; SD: Standard Deviation; CI: Confidence Intervals; GAD-7: Generalised Anxiety Questionnaire-7; CAQ: Cardiac Anxiety Questionnaire; FFMQ: Five Facet 
Mindfulness Questionnaire; SCS: Self-Compassion Scale; PANAS: Positive and Negative Affect Scale; IPQ-R: Illness Perception Questionnaire-Revised. SAQ: Seattle Angina Questionnaire;  
* CAQ was completed by participants with heart conditions only (MBCT, n=6; MBSR, n=5; TAU, n=3); ** SAQ was completed by participants with heart conditions only (MBCT, n=6; 
MBSR, n=5; TAU, n=3).  
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Table 5 
Comparison of secondary outcomes at 3-month follow-up 
Outcomes 
MBCT-HeLM 
(N= 11) 
MBSR 
(N= 10) 
TAU 
(N= 8) 
 
MBCT-HeLM vs. MBSR 
 
MBCT-HeLM vs. TAU 
Mean (SD) Mean (SD) Mean (SD)  Mean diff. 95% CI  Mean diff. 95% CI 
Blood pressure          
 Systolic blood pressure (mmHg) 122.6 (16.3) 130.4 (14.1) 127.8 (14.8)  -7.8 -26.4 to 10.8  -5.2 -24.3 to 13.9 
 Diastolic blood pressure (mmHg) 65 (20.5) 73 (15.2) 70.7(9.6)  -8.0 -29.9 to 13.9  -5.7 -24.8 to 13.4 
GAD-7 3.2 (2.4) 3.5 (1.6) 8.0 (5.0)  -0.3 -2.4 to 1.8  -4.8 -8.6 to -0.9 
CAQ* 16.6 (10) 23.0 (4.9) 30.0 (6.2)  -6.3 -17.5 to 4.8  -13.3 -26.4 to -0.2 
RAND 36-Item Health Survey 1.0          
 RAND 36-Item Physical 51.6 (21.4) 59.1 (24.4) 54.9 (32.4)  -7.5 -29.0 to 14.0  -3.3 -32.1 to 25.7 
 RAND 36-Item Psychological 63.8 (18.2) 61.3 (18.3) 51.6 (20.9)  2.5 -14.8 to 19.8  12.1 -6.9 to 31.2 
FFMQ (Total) 125 (19.0) 131 (26.4) 115 (14.6)  -6.0 -28.0 to 14.8  10.0 -7.3 to 26.7 
SCS (Total) 2.8 (.51)   2.9 (0.69) 2.7 (0.6)  -0.1 -0.8 to 0 .4  0.1 -0.1 to 1.0 
PANAS-Positive 27.9 (6.1) 32.1 (9.8) 28.3 (9.9)  -4.2 -11.8 to 3.4  -0.4 -8.2 to 7.3 
PANAS-Negative 18.6 (7.4) 18.8 (7.7) 17.3 (9.6)  -0.2 -7.9 to 6.4  0.8 -7.4 to 9.0 
IPQ-R          
 IPQ-R timeline acute/chronic  21.3 (5.5) 23.8 (4.1) 26.7 (3.5)  -2.6 -7.5 to 2.3  -5.5 -10.2 to -0.7 
 IPQ-R timeline cyclical 11.5 (3.7) 10.0 (3.7) 11.4 (4.7)  1.5 -2.1 to 5.2  0.2 -3.9 to 4.2 
 IPQ-R consequences 18.3 (4.9) 20.4 (5.8) 20.6 (5.6)  -2.1 -7.3 to 3.1  -2.4 -7.4 to 2.7 
 IPQ-R personal control 22.1 (3.5) 23.5 (3.6) 21.6 (4.4)  -1.4 -4.9 to 2.1  0.5 -3.4 to 4.3 
 IPQ-R treatment control 17.0 (2.6) 17.3 (2.9) 19.0 (2.7)  -0.3 -3.0 to 2.5  -2.0 -4.6 to 0.6 
 IPQ-R illness coherence 19.3 (4.0) 18.1 (5.1) 20.0 (4.3)  1.1 -3.2 to 5.5  -0.7 -4.7 to 3.2 
 IPQ-R emotional representations 17.9 (4.8) 18.6 (6.1) 17.8 (6.1)  -0.7 -6.0 to 4.6  0.1 -5.1 to 5.4 
SAQ**          
 SAQ- physical limitations 46.6 (14.2) 43.5 (19.5) 48.1 (19.5)  3.1 -18.9 to 25.1  -1.5 -28.1 to 25.1 
 SAQ- angina stability 63.3 (15.0) 50.0 (24.5) 40.0 (17.0)  13.3 -12.8 to 39.5  23.3 -4.1 to 50.8 
 SAQ- angina frequency 72.2 (10.0) 66.6 (11.7) 75.0 (11.7)  5.6 -8.6 to 19.7  -2.8 -23.5 to 17.9 
 SAQ- treatment satisfaction 63.4 (8.8) 62.6 (11.0) 64.2 (16.8)  0.8 -12.1 to 13.7  -0.8 -22.0 to 20.4 
 SAQ- disease perception 56.6 (13.1)  51.1 (19.6) 46.0 (28.2)  5.6 -15.9 to 27.1  10.0 -23.3 to 43.3  
Note: TAU: Treatment As Usual; SD: Standard Deviation; CI: Confidence Intervals; GAD-7: Generalised Anxiety Questionnaire-7; CAQ: Cardiac Anxiety Questionnaire; FFMQ: Five Facet 
Mindfulness Questionnaire; SCS: Self-Compassion Scale; PANAS: Positive and Negative Affect Scale; IPQ-R: Illness Perception Questionnaire-Revised. SAQ: Seattle Angina Questionnaire; * 
CAQ was completed by participants with heart conditions only (MBCT, n=6; MBSR, n=5; TAU, n=3); ** SAQ was completed by participants with heart conditions only (MBCT, n=6; MBSR, 
n=5; TAU, n=4).  
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Table 6 
Themes and sample quotes from the HeLM acceptability interviews  
Themes Summary  Quotes 
Diversity of 
expectations   
 
Participants joined the course with different expectations of it. Two hoped 
to get benefit for their heart condition and high blood pressure as well as 
their depression. Another two wanted something to help with their 
depression and anxiety, so they could see things in a different and calmer 
way. One woman joined the course as she had a personal interest in 
learning cognitive therapy and meditation. One other participant joined the 
course without any expectations and he reported that he had no enough 
information about the course.   
“Well basically that I'd come out feeling calmer and look at things in a 
different perspective. Instead of being a black and white person seeing things 
in a calmer way perhaps” (Participant 3) 
 
“I wanted to know about depression. Because you never know enough about 
it and maybe that's probably why we're depressed because we don't know 
enough how we need to avoid some things (Participant 7) 
Motivation  
The reasons that made people to take part in the course were different, such 
as meeting other people, the experience its self (e.g., trying new things, 
coming to the university or learning meditation). One participant said that it 
was an opportunity and he thought he should take advantage of it. Other 
participants pointed out that the nature of MBCT, as a kind of 
psychotherapy, would not cause them any harm.  
Another mentioned attending so it would be possible to avoid psychiatric 
medications. Two participants wanted to deal with their physical conditions 
(heart conditions and blood pressure) and depression. Another two 
participants wanted to get help with their depression.  
“I wanted something to help me, I felt I needed some help with my  
condition both with the mental condition I found myself in after I got ill and 
the illness itself and I thought anything like this is at least worth trying” 
(Participant 2)  
 
“Because at the time I was feeling rather down, and I thought it would be a 
way of speaking to somebody, mixing with different people and 
communicating to me is pretty important anyway” (Participant 3) 
“I'm a supporter of anything that will take us away from chemicals. This is 
not a chemical or a physical intervention, it's about the mind. and therefore, 
you can only benefit from it” (Participant 5) 
Challenges  
1.Being in 
group 
 
Five of the seven participants joined the group with some worries around 
being in a group, mainly being worried about talking to new people, talking 
about personal issues with others and/or due to a language barrier. However, 
these people’s experience was positive, with reporting that the environment 
was encouraging, and they worked well as a team. One of the things that 
seemed to help people to deal with their worries is that there was no pressure 
to talk or share feelings about depression or their physical symptoms, such 
as having a heart attack or stroke, if they did not wish to do so. Participant 1 
did not see the course as a group therapy but more as an opportunity to share 
personal experiences with others, while Participant 5 said that being in a 
group helped in not being introspective.   
“Oh, my God, I was worried. First because of my language and second it 
was really difficult to meet new people, you know that feeling, having 
looked at you, you know, maybe someone start to ask you know what you've 
done before but yes it was a really different experience I was talking to nice 
people” (Participant 7).  
“I haven't ever taken part in what I understand to be group therapy, but I 
think it is people sharing their experiences” (Participant 1)  
“I think that if it were not a group it would be very easy to become 
extremely introspective in your perceptions of what was going on and why 
you were doing it. When you have a group, there is this group thing that 
takes over”. (Participant 5) 
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 Table 6 
Themes and sample quotes from the HeLM acceptability interviews (cont.) 
Themes Summary  Quotes 
2. Making 
mindfulness 
a priority 
Four participants agreed that making the course a priority in their lives had 
been a challenge for them. They reported how they needed to push 
themselves and had to allocate time to undertaking homework every day.  
“If I were in your position I would be very aware that people have 
difficulties and you have to persuade them to priorities this project, the 
exercises” (Participant 5). 
Effective 
techniques 
1. Orientation session:  
The seven participants seemed to agree that the orientation session with the 
therapist was very helpful in terms of providing good information about the 
course and what was going happen. They reported that the therapist was 
easy to talk to.  
2. Exercises:  
The seven participants agreed that the 3-step breathing space was useful for 
different reasons. For example, participant 5 thought that it is short and that 
it suited his lifestyle as he could use it anywhere, while participant 2 said 
that he felt better regarding his breathing with this exercise.  
The body scan was useful for four participants. For example, participant 1 
described her experience with it as it helped her to see how lucky she was 
comparing to other people who had physical problems.  
Also, talking to other people and the therapist seemed to be helpful to some 
participants.  
3. Homework and Questionnaires 
Participants 1, 3, 6 and 7 described their experience with doing homework 
as being easy, but they had to allocate time to undertaking it. Participant 4 
thought that it was demanding. Participants 2 and 5 thought that the 
homework was flexible, and it had helped them to do what they wanted to 
do.   
Regarding the questionnaires, participants agreed that completing them was 
fine. However, some said that some items did not apply to them and some 
were repetitive.  
4. The course overall 
It seemed that the course as overall was acceptable to people. For example, 
three participants liked how flexible it was. Participant 1 described the 
course as delivering “A more relaxed attitude to life”.  
“The breathing space suits my life and the way I live” (Participant 5). 
 
“When I'm faced with a stressful situation the first thing that happens is my 
breathing shuts down a little bit, there is already a heart condition that causes 
a problem with that so it's twice as bad but then I think about the responsive 
breathing, the breathing practice and It does seem to help there's no doubt 
about that” (Participant 2). 
“It was quite demanding and filling in the forms but then if you didn't have 
the forms I think there wouldn't have been the incentive to keep going so yes 
it was quite demanding, but I think it probably needed to be quite 
demanding” (Participant 4). 
“A more relaxed attitude to life. I remember we were asked that question in 
the group and the answer just came to me. I hadn't articulated it before. I felt 
that the words had been put into my mouth almost without having to think 
about them” (Participant 1). 
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 Table 6 
Themes and sample quotes from the HeLM acceptability interviews (cont.) 
Themes Summary  Quotes 
Ineffective 
 techniques    
1. Exercises:  
Six out of the seven participants found that the movement exercise was not 
helpful. Four said that as they had other physical complaints that limited 
their ability to do it. Participant 3 said that it was very slow, so she did not 
like it. While participant 7 thought that it did not help her to feel calm. 
However, participant 5, who had hypertension, found this exercise helpful. 
2. Handouts. Participant 2 pointed to that there was a need to emphasise 
more the fact that this course was for people with CVD. He also mentioned 
that some of terms in the handout needs to be explained further, such as 
automatic pilot.  
 
“Do you know I've gone to the whole 8 weeks and this business about it 
being special for heart conditions, hasn't really been emphasized very 
much. I know that's what you've got because you've got two groups, a 
control group and all the rest of it but there wasn't a lot of mention of that of 
the physical side of people's conditions in the course. It was about the 
mindfulness itself” (Participant 2). 
Physical 
/Psychological 
benefits    
The benefits that participants obtained from the course were mainly around 
breathing, understanding depression and facing stress. For example, two 
participants reported that the course had helped them regarding their 
breathing and three said that it was helpful in terms of having another way 
of controlling stress as well as providing them with a different way of seeing 
things. One participant thought that after having the course she was able to 
understand depression better.   
 
“I think it's helped some of the way I think about things, not necessarily to 
do with my illness but maybe to do with if I feel depressed I can think 
'these are just thoughts' I try to if I'm thinking very negative thoughts I 
could sometimes look at the thoughts and think I don't need to think like 
this, so it had helped me” (Participant 4). 
 
“First I feel very clear about that now, about depression and that so I can 
explain to someone myself what this is and how you can fight that” 
(Participant 7). 
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Figure 1. CONSORT Diagram of HeLM Participant Flow 
